Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA Revitalization Bill Clears House, Heads For Conference

This article was originally published in The Tan Sheet

Executive Summary

The House followed the Senate July 11 in passing "FDA Revitalization" legislation calling for greater access to more medicines and strengthening the agency's post-marketing authority

You may also be interested in...



FDA Re-Org Makes Chief Of Staff Liaison Between Centers, Commissioner

The newly created FDA Office of the Chief of Staff will serve as the major point of contact for communication from FDA centers and offices to the commissioner, according to an Aug. 30 Federal Register notice

FDA Re-Org Makes Chief Of Staff Liaison Between Centers, Commissioner

The newly created FDA Office of the Chief of Staff will serve as the major point of contact for communication from FDA centers and offices to the commissioner, according to an Aug. 30 Federal Register notice

FDA Re-Org Makes Chief Of Staff Liaison Between Centers, Commissioner

The newly created FDA Office of the Chief of Staff will serve as the major point of contact for communication from FDA centers and offices to the commissioner, according to an Aug. 30 Federal Register notice

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS100707

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel